Pitt Enzyme Discovery May Lead To Better Tests For Tuberculosis
Tuberculosis is one of the most deadly global bacterial infections, killing more than 2 million people worldwide annually. Doctors see 9 million new cases of the disease every year, mostly in Africa and Southeast Asian countries, although small outbreaks of the disease have been reported in urban areas of the United States. Tuberculosis is caused by bacteria called Mycobacterium tuberculosis. The TB bacteria usually attack the lungs and are spread through the air from one person to another.
"It's a huge public health burden," said Anil Ojha, Ph.D., assistant professor in the Department of Infectious Diseases and Microbiology at Pitt Public Health, and senior author of the study. "Clearly, controlling the infection is heavily dependent upon an effective diagnosis."
The current bacterial culture test for TB infections is highly accurate but time-consuming, taking up to several weeks.
"That may create a race against time for a patient who has acute tuberculosis infection," said Dr. Ojha. "That's why our process is so important. It can obtain results that are both rapid and accurate."
The World Health Organization (WHO) currently recommends a diagnostic technique called nucleic acid-based amplification (NAA); however, this process faces difficulty in breaking open, or lysing bacteria, to access nucleic acids. Mycobacteria are shaped by a thick envelope of fats and sugars, and are resistant to most of the chemicals conventionally used to lyse bacteria.
Pitt Public Health researchers found that exposure to an esterase, an enzyme that targets fatty acids on the surface of the mycobacterial envelope, led to rapid lysis of the bacilli. Researchers also demonstrated that this quick lysis of Mycobacterium tuberculosis improved its detection at lower density.
"Discovery of enzyme-based mycobacteria lysis has the potential to increase the sensitivity of NAA," said Dr. Ojha.
Collaborators on this study include: Yong Yang, Ph.D., Alexandra Bhatti, M.P.H., Danxia Ke, and Peijun Zhang, Ph.D., all of the University of Pittsburgh; Mercedes Gonzalez-Juarrero, Ph.D., and Anne Lenaerts, Ph.D., both of Colorado State University; Laurent Kremer, Ph.D., of the University of Montpellier; and Yann Guerardel, of the French National Center for Scientific Research.
The research was funded by NIH grants AI079288 and GM085043.
Source: University of Pittsburgh Graduate School of Public Health
Please use one of the following formats to cite this article in your essay, paper or report:
University of Pittsburgh. "Pitt Enzyme Discovery May Lead To Better Tests For Tuberculosis." Medical News Today. MediLexicon, Intl., 9 Jan. 2013. Web.
26 Aug. 2016. <http://www.medicalnewstoday.com/releases/254699.php>
University of Pittsburgh. (2013, January 9). "Pitt Enzyme Discovery May Lead To Better Tests For Tuberculosis." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.